Covid-19 Response and Statement
Update to participants on COVID19 and Brexit March 2021
UK NEQAS LI Update on COVID19 and Brexit[...]
Adobe Acrobat document [160.3 KB]
Message from UK NEQAS Board of Trustees:
Message from UK NEQAS Board of Trustees.[...]
Adobe Acrobat document [138.4 KB]
Local Message from UK NEQAS for Leucocyte Immunophenotyping:
Local Message from UK NEQAS for Leucocyt[...]
Adobe Acrobat document [130.7 KB]
COVID-19 - EQA Sample Processing Information
COVID-19 - EQA Sample Processing Informa[...]
Adobe Acrobat document [132.6 KB]
Risk Assessment for the Continued Use of H100D Laboratory (and Associated Areas) During the Period of SARS-COV2 Pandemic
Risk Assessment for the Continued Use of[...]
Adobe Acrobat document [412.1 KB]
COVID-19 Risk Assessment - Safe Working Practices in Non Clinical Areas
COVID-19 Risk Assessment - Safe Working [...]
Adobe Acrobat document [657.7 KB]
To request an extension to the deadline for data entry for any trial (due to the COVID-19 pandemic), please click here.
Service Updates:
Our services are now running at normal capacity. Any deviation from the trial schedule will be indicated here;
Last Updated: 15/12/2021
Print
Sitemap
Follow Us Online: Facebook Twitter LinkedIn Youtube
Available Links: Disclaimer | Privacy Policy | Cookie Policy (This website uses cookies)
Last updated 05/08/2025 © UK NEQAS for Leucocyte Immunophenotyping. Not to be reproduced in whole or part without permission.
UK NEQAS is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).